Skip to main content
      Rheumatoid arthritis treatment has come leaps and bounds in recent decades. Gone are the days of gold injections, chemical synovectomies, and physician-mandated bedrest (heaven forbid). Though the marketplace for RA treatments is becoming ever more crowded, there are still unmet needs.
      The updated 2022 EULAR recommendations for the management of rheumatoid arthritis (RA) were initially presented by Dr. Josef Smolen at EULAR 2022, and are now in press delineating the most recent developments and perspectives in RA treatment.
      Dr. Yuz Yusof will be covering #ACR22 as a RheumNow reporter again. He'll be sharing real-time coverage on SLE, auto-in

      Dr. John Cush RheumNow

      3 years 10 months ago
      Dr. Yuz Yusof will be covering #ACR22 as a RheumNow reporter again. He'll be sharing real-time coverage on SLE, auto-inflammatory and COVID. Follow @Yuz6Yusof! https://t.co/3rYlIrM54m
      As we approach ACR22, there are many things to be excited about, especially with the reintroduction of in-person attendance. My attention this year is in research being presented in these three areas: ankylosing spondylitis; lupus management and treatment; and, subclinical RA.
      Follow RheumNow reporter, Dr. Eric Dein, for real-time #ACR22 coverage! https://t.co/NZkVd2A989

      Dr. John Cush RheumNow

      3 years 10 months ago
      Follow RheumNow reporter, Dr. Eric Dein, for real-time #ACR22 coverage! https://t.co/NZkVd2A989
      Our newest RheumNow reporter, Dr. Michael Putman , will be covering SLE and Vasculitis at #ACR22 this year.

      “Lookin

      Dr. John Cush RheumNow

      3 years 10 months ago
      Our newest RheumNow reporter, Dr. Michael Putman , will be covering SLE and Vasculitis at #ACR22 this year. “Looking forward to seeing all my friends and colleagues in person!”-Dr. Putnam Follow him @EBRheum for real-time coverage! https://t.co/DpFa0zwzPX
      We're excited to have Dr. Aurelia Najm back as an #ACR22 RheumNow reporter!

      "I look forward to learning about developme

      Dr. John Cush RheumNow

      3 years 10 months ago
      We're excited to have Dr. Aurelia Najm back as an #ACR22 RheumNow reporter! "I look forward to learning about developments in the field and finally meet with colleagues and collaborators from all over the world. " -Dr. Najm Follow @AurelieRheumo for real time #ACR22 coverage! https://t.co/o6Mhobt2BR
      Dr. Robert Chao is back as a RheumNow reporter for a third year.

      "I’m looking forward to the exciting hybrid format o

      Dr. John Cush RheumNow

      3 years 10 months ago
      Dr. Robert Chao is back as a RheumNow reporter for a third year. "I’m looking forward to the exciting hybrid format of both in person and virtual meeting this year! " Follow @doctorRBC for real-time #ACR22 coverage! https://t.co/j6FNra7aZq
      Join Dr. Jack Cush and Dr. Arthur Kavanaugh as they discuss, dissect and deliberate about data presented at the #ACR22 m

      Dr. John Cush RheumNow

      3 years 10 months ago
      Join Dr. Jack Cush and Dr. Arthur Kavanaugh as they discuss, dissect and deliberate about data presented at the #ACR22 meeting in Philadelphia. https://t.co/STvWZMS7xS https://t.co/oQt3ZMyjEN
      2022 EULAR Recommendations for Screening and Prophylaxis of Chronic and Opportunistic Infections

      A EULAR Task force h

      Dr. John Cush RheumNow

      3 years 10 months ago
      2022 EULAR Recommendations for Screening and Prophylaxis of Chronic and Opportunistic Infections A EULAR Task force has developed recommendations for screening and prophylaxis of chronic and opportunistic infections in patients with AIIRD. https://t.co/VrdNggfMfG https://t.co/WARs0YJLZs
      On Sunday Nov. 13, 2022, at ACR Convergence 2022 meeting, the ACR will present a new guideline for Exercise, Rehabilitation, Diet and Additional Integrative Interventions for Rheumatoid Arthritis.
      Americans’ willingness to use video telehealth has increased since the beginning of the COVID-19 pandemic, rising most sharply among Black Americans and people with less education, according to a new RAND Corporation study.
      ×